Two major deals for Sheffield software firm
A Sheffield software company has landed deals to improve performance at a research centre and for an arthritis charity.
Razor will use its knowledge of AI, machine learning and big data to ‘transform’ the work of the Advanced Manufacturing Research Centre in Rotherham.
The aim is to boost the AMRC’s research for manufacturers, from Boeing to Sheffield-based small firms, and provide a showcase that inspires companies to upgrade. Razor is one of three tech firms to work on the project which is set to last four years and is worth up to £2m.
The deal comes a week after the company won a contract to use artificial intelligence to improve services at charity Versus Arthritis.
The one-year project will help it improve how medical research is managed, communicated and tailored to patients.
Jamie Hinton, Razor chief executive and co-founder at Razor, said the AMRC deal came after they helped the centre improve production at an aerospace company 4,000 times better than expected.
He added: “This partnership is huge for us at Razor, and we’re delighted our two organisations are coming together. Both Razor and the AMRC believe in the potential of our region, we are on the cusp of a new industrial revolution fuelled by relationships like ours, which supercharge the connection between digital and advanced manufacturing. We can’t wait to get started.”
The project for Versus Arthritis will focus on building on existing tools and developing new products. The deal is planned to last a minimum of 12 months.
Ellie Mosley, head of client services at Razor, said: “As a business, we are passionate about helping companies deliver on technology which puts people first. This partnership brings that mission into sharp focus. Everything we deliver for Versus Arthritis will be geared up towards helping the huge number of people with arthritis and their families which the charity serves.
“Our team will be working with the newest AI technology, harnessing data across a broad landscape. What we’re planning to deliver will ensure Versus Arthritis is locating the right knowledge at the right time for patients and for internal research programmes. We can’t wait to help develop innovative new ways of working for the charity.”